FDA Investigator: Joseph D. Doleski
- Joseph D. Doleski first started conducting FDA inspections in 2006, with the last inspection in 2012. Over that time, Joseph D. Doleski has conducted 14 inspections at 14 companies across 14 sites.
Get Joseph Doleski's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Lonza Biologics Tuas Pte Ltd, Tuas | 2012
Out-of-stock
Joseph D. Doleski
Human Drug Form 483
FDA 483 Ortho-Clinical Diagnostics, Inc., Raritan | 2010
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 Merck and Co Inc., Durham | 2010
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 Novartis Vaccines and Diagnostics Limited, Liverpool | 2009
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 Novartis Vaccines And Diagnostics Srl, Sovicille | 2008
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 Sanquin Plasma Products, Amsterdam | 2007
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 CAF-DAF scrl, Neder-over- Heembeek | 2007
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 Lonza Walkersville, Inc., Walkersville | 2007
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 Merck Sharpe & Dohme Corp, West Point | 2006
Out-of-stock
Joseph D. Doleski
Biologic Form 483
FDA 483 ID Biomedical Corp., a subsidary of GSK Biologicals, St. Foy | 2006
Out-of-stock
Joseph D. Doleski
Biologic Form 483